Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC has released a White Paper "Innovative Payment Schemes for Medical Devices"

MTRC is pleased to announce the release of its latest White Paper: "Innovative Payment Schemes for Medical Devices".

Our latest White Paper offers a summary of innovative payment schemes for medical devices that permit direct applications by the Med Tech industry, including the Innovative Devices Access Pathway (IDAP) in the UK, Forfait Innovation and Article 51 in France, and co-funded clinical studies under §137e in Germany.

This resource equips market access professionals with insights to effectively navigate these frameworks, utilize innovative payment schemes to secure early reimbursement for medical technologies, and position their innovations for success within the evolving European healthcare landscape. 

Read more and request a White Paper here.